In recent years, the world has witnessed the devastating impact of the COVID-19 pandemic, which has caused significant loss of life and economic disruptions across nations. As one of the most effective tools for identifying COVID-19, chest X-rays have played a crucial role in diagnosing and monitoring the progression of the disease. However, the manual interpretation of these images by healthcare professionals can be time-consuming and subjective, often leading to delays in diagnosis and potential errors.
In addition to COVID-19, there are numerous other respiratory and chest-related diseases that require accurate and timely detection, such as pneumonia, tuberculosis, and lung cancer. Early detection of these diseases is vital for effective treatment and improved patient outcomes. Unfortunately, healthcare systems in many parts of the world, including Myanmar, face resource constraints, limited access to specialized expertise, and a lack of sophisticated diagnostic tools. These challenges hinder the timely detection and appropriate management of respiratory diseases, leading to increased morbidity and mortality rates.
To address these critical issues, the Omdena Myanmar Chapter has initiated the “Identifying Diseases in Chest X-Rays & COVID-19 Detection” project. The goal is to leverage deep learning techniques to develop an automated system capable of accurately detecting COVID-19 and various chest-related diseases from radiographic images. By harnessing the power of artificial intelligence and computer vision, this project aims to revolutionize the diagnostic process and facilitate early intervention, ultimately saving lives and improving healthcare outcomes.
The problem we aim to solve through this project is two-fold. Firstly, the lack of accessible and reliable diagnostic tools for chest diseases, including COVID-19, hampers timely detection and intervention, which can lead to the rapid spread of the disease and its associated complications. Secondly, the scarcity of specialized healthcare professionals, particularly radiologists, in many parts of Myanmar, exacerbates the problem by limiting the availability of accurate and prompt diagnoses.
Our local community faces the burden of inadequate healthcare infrastructure and limited resources, which further amplifies the impact of these challenges. Early detection of COVID-19 and other chest diseases is crucial for effective treatment and preventing the spread of the virus. By deploying an AI-powered solution capable of accurately analyzing chest X-rays and identifying diseases, we can make a significant positive impact on the healthcare landscape of Myanmar, Asian countries, and people around the world.
The deep learning model we develop will enable healthcare providers, including general practitioners and healthcare workers in remote areas, to quickly identify diseases in chest X-rays. By reducing the dependence on scarce human resources and improving the efficiency of diagnoses, our solution will enhance the overall quality of healthcare services. Moreover, the availability of a reliable and accessible diagnostic tool will empower medical professionals to make informed decisions and provide timely treatments, potentially saving lives and mitigating the spread of diseases within the community. **The productivity of our product will increase as much as the support we receive**, as our model is greatly dependent on the support of data.
Through the development of a web app or mobile app, we aim to make this solution widely accessible beyond our local community, reaching healthcare providers globally. By democratizing access to advanced diagnostic capabilities, we strive to contribute to the global fight against COVID-19 and other chest diseases, fostering a healthier future for individuals worldwide.
– Literature review and refinement of goals.
– Setup of development environments
– Data Collection
– Exploratory data analysis (EDA)
– Data Preprocessing
– Model development
– Models improvement
– Develop a web app or mobile app
– Project Overview
– Final Presentation